Rongshu Shi

机构：Zunyi Medical University, Affiliated Hospital of Guizhou Medical University, Affiliated Hospital of Zunyi Medical College

发表论文 6 篇 · 总被引 85 次 · h-index 3

代表论文

• Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial (2025 · The Lancet Oncology · 被引 49)
• Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature (2020 · Bioscience Reports · 被引 22)
• Construction of AP003469.4-miRNAs-mRNAs ceRNA network to reveal potential biomarkers for hepatocellular carcinoma. (2022 · PubMed · 被引 11)
• Removal of "ruptured" pulmonary artery infusion port catheter by pigtail catheter combined with gooseneck trap: A case report (2021 · World Journal of Clinical Cases · 被引 3)
• Recombinant Human Thrombopoietin Reduces the Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia (2026 · American Journal of Hematology)
• High-Risk Factors and Prognostic Modeling for Short-Term Death Following TACE in Liver Cancer Patients (2024)